The global legal marijuana market size is calculated at USD 42.02 billion in 2025 and is forecasted to reach around USD 251.51 billion by 2034, accelerating at a CAGR of 22.16% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Legal Marijuana Market, by Product Type,
7.1.1. Oils
7.1.1.1. Market Revenue and Forecast
7.1.2. Buds
7.1.2.1. Market Revenue and Forecast
7.1.3. Tinctures
7.1.3.1. Market Revenue and Forecast
8.1. Legal Marijuana Market, by Application,
8.1.1. Mental Disorders
8.1.1.1. Market Revenue and Forecast
8.1.2. Chronic Pain
8.1.2.1. Market Revenue and Forecast
8.1.3. Cancer
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast
9.1. Legal Marijuana Market, by Marijuana,
9.1.1. Medical
9.1.1.1. Market Revenue and Forecast
9.1.2. Adult Use
9.1.2.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product
10.1.2. Market Revenue and Forecast, by Application
10.1.3. Market Revenue and Forecast, by Marijuana
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product
10.1.4.2. Market Revenue and Forecast, by Application
10.1.4.3. Market Revenue and Forecast, by Marijuana
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product
10.1.5.2. Market Revenue and Forecast, by Application
10.1.5.3. Market Revenue and Forecast, by Marijuana
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product
10.2.2. Market Revenue and Forecast, by Application
10.2.3. Market Revenue and Forecast, by Marijuana
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product
10.2.4.2. Market Revenue and Forecast, by Application
10.2.4.3. Market Revenue and Forecast, by Marijuana
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product
10.2.5.2. Market Revenue and Forecast, by Application
10.2.5.3. Market Revenue and Forecast, by Marijuana
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product
10.2.6.2. Market Revenue and Forecast, by Application
10.2.6.3. Market Revenue and Forecast, by Marijuana
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product
10.2.7.2. Market Revenue and Forecast, by Application
10.2.7.3. Market Revenue and Forecast, by Marijuana
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product
10.3.2. Market Revenue and Forecast, by Application
10.3.3. Market Revenue and Forecast, by Marijuana
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product
10.3.4.2. Market Revenue and Forecast, by Application
10.3.4.3. Market Revenue and Forecast, by Marijuana
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product
10.3.5.2. Market Revenue and Forecast, by Application
10.3.5.3. Market Revenue and Forecast, by Marijuana
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product
10.3.6.2. Market Revenue and Forecast, by Application
10.3.6.3. Market Revenue and Forecast, by Marijuana
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product
10.3.7.2. Market Revenue and Forecast, by Application
10.3.7.3. Market Revenue and Forecast, by Marijuana
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product
10.4.2. Market Revenue and Forecast, by Application
10.4.3. Market Revenue and Forecast, by Marijuana
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product
10.4.4.2. Market Revenue and Forecast, by Application
10.4.4.3. Market Revenue and Forecast, by Marijuana
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product
10.4.5.2. Market Revenue and Forecast, by Application
10.4.5.3. Market Revenue and Forecast, by Marijuana
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product
10.4.6.2. Market Revenue and Forecast, by Application
10.4.6.3. Market Revenue and Forecast, by Marijuana
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product
10.4.7.2. Market Revenue and Forecast, by Application
10.4.7.3. Market Revenue and Forecast, by Marijuana
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Market Revenue and Forecast, by Marijuana
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product
10.5.4.2. Market Revenue and Forecast, by Application
10.5.4.3. Market Revenue and Forecast, by Marijuana
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product
10.5.5.2. Market Revenue and Forecast, by Application
10.5.5.3. Market Revenue and Forecast, by Marijuana
11.1. Aurora Cannabis
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. GW Pharmaceuticals, plc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Organigram Holding, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Canopy Growth Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Maricann Group, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Aphria, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Maricann Group, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. The Cronos Group
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Tilray
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. ABcannMedicinals, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Lexaria Corp.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample